Sectors

ICCM
IceCure Medical Ltd
3.08
1 x 3.00
1 x 3.43
bid
ask
+
0.00
0.00%
25 @ 04:00 PM
3.07 -0.01 (0.31%)
Ytd-83.17%
1y-88.45%
2.99
day range
3.20
2.12
52 week range
42.00
Open3.14Prev Close3.08Low2.99High3.20Mkt Cap6.94M
Vol44.75KAvg Vol3.50MEPS-3.72P/E-0.83Forward P/E-4.48
Beta2.63Short Ratio0.46Inst. Own0.40%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1250-d Avg4.45200-d Avg13.991yr Est3.37

ICCM News

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Gainers AbCellera Biologics (NASDAQ:ABCL) shares increased by 8.2% to $7.5 during Friday's afte

IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment
prnewswire.com
IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study fo

Adventist Health Glendale is the first site able to enroll patients in the ChoICE Study after signin

IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026
prnewswire.com
IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026

CAESAREA, Israel, Aug. 5, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceC

IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®
prnewswire.com
IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing Ic

The petition by The Society of Interventional Oncology (SIO) includes adding criteria for patients a

IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site
prnewswire.com
IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment

Company signed agreement with the West Cancer Center & Research Institute, the first clinical site f

IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation
prnewswire.com
IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation

CAESAREA, Israel, July 14, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure," "Ice

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-mark

IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer
prnewswire.com
IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA C

Growing physician interest and commercial adoption for ProSense™ in Brazil's expanding interventiona

IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement
prnewswire.com
IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement

CAESAREA, Israel, June 25, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "Ice

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers Pulsenmore (NASDAQ:PLSM) shares moved upwards by 160.5% to $8.88 during Wednesday's reg

KB Home Posts Upbeat Q2 Sales, Joins Inmode, Icon And Other Big Stocks Moving Higher On Wednesday
benzinga.com
KB Home Posts Upbeat Q2 Sales, Joins Inmode, Icon And Other Big Stocks Moving Higher On Wednesday

U.S. stocks rose, with Nasdaq up 50 points. KB Home (NYSE: KBH) reported strong Q2 results, shares j

IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer
prnewswire.com
IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoa

Published in the International Journal of Surgery, globally ranked in the top three among surgery jo

Apogee Therapeutics, Definium Therapeutics, Baldwin Insurance And Other Big Stocks Moving Higher On Monday
benzinga.com
Apogee Therapeutics, Definium Therapeutics, Baldwin Insurance And Other Big Stocks Moving Higher On

U.S. stocks up with Dow Jones gaining 200+ points. AbbVie Inc. announced acquisition of Apogee Thera

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor
prnewswire.com
IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price

CAESAREA, Israel, June 17, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "Ice

IceCure Stock Surges After 70% ProSense Install Increase
benzinga.com
IceCure Stock Surges After 70% ProSense Install Increase

IceCure Medical Ltd. (NASDAQ:ICCM) shares are soaring Wednesday after the company reported a 70% jum

IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance
prnewswire.com
IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Fol

Increase driven by FDA clearance, clinical guideline support, and increased physician demand. Signif

Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com
Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures rise, Nasdaq up 1%. Graham Corp shares down 8.7%. Other stocks declining in pre-m

IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance
prnewswire.com
IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance

Proactive Step to Regain Nasdaq Compliance as Part of the Company's Broader Capital Markets Strategy

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

IceCure's ProSense® Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked
prnewswire.com
IceCure's ProSense® Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data

At the annual European Conference on Interventional Oncology, ICESECRET data presented demonstrated

IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
prnewswire.com
IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

No Immediate Effect on Nasdaq Listing or Trading of the Company's Ordinary Shares CAESAREA, Israel,

IceCure Medical Ltd (ICCM) Q1 2026 Earnings Call Transcript
seekingalpha.com
IceCure Medical Ltd (ICCM) Q1 2026 Earnings Call Transcript

IceCure Medical Ltd (ICCM) Q1 2026 Earnings Call Transcript

IceCure Medical Ltd. (ICCM) Reports Q1 Loss, Lags Revenue Estimates
zacks.com
IceCure Medical Ltd. (ICCM) Reports Q1 Loss, Lags Revenue Estimates

IceCure Medical Ltd. (ICCM) came out with a quarterly loss of $0.06 per share versus the Zacks Conse

IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America
prnewswire.com
IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the

Pent-up demand immediately following FDA clearance generates 46% increase in active customer account

Earnings Scheduled For May 12, 2026
benzinga.com
Earnings Scheduled For May 12, 2026

IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026
prnewswire.com
IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026

CAESAREA, Israel, May 6, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCu

IceCure Showcases ProSense® Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market
prnewswire.com
IceCure Showcases ProSense® Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting

As the only FDA cleared minimally invasive treatment option for low-risk breast cancer, ProSense® is

IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025
prnewswire.com
IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases

The Company's participation at the Society of Breast Imaging Symposium and other upcoming medical co

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Earnings Scheduled For March 17, 2026
benzinga.com
Earnings Scheduled For March 17, 2026

10 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
10 Health Care Stocks Moving In Monday's Pre-Market Session

Earnings Scheduled For November 19, 2025
benzinga.com
Earnings Scheduled For November 19, 2025

benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga.com
Earnings Scheduled For August 13, 2025

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  During Friday's session, 574 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 400 companies set new 52-week lows.